(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
0.23% $ 13.02
Live Chart Being Loaded With Signals
Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases...
Stats | |
---|---|
Dzisiejszy wolumen | 34 863.00 |
Średni wolumen | 46 458.00 |
Kapitalizacja rynkowa | 12.65B |
EPS | $0 ( 2024-03-31 ) |
Następna data zysków | ( $0 ) 2024-05-12 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.150 |
ATR14 | $0.0560 (0.43%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-13 | 5am Partners Vii, Llc | Buy | 450 000 | Common Stock |
2024-03-13 | Schwab Andrew J. | Buy | 450 000 | Common Stock |
2024-02-29 | Grayson Paul A. | Buy | 100 000 | Common Stock |
2024-02-29 | Grayson Paul A. | Buy | 35 000 | Stock Option (Right to Buy) |
2024-02-29 | Charych Deborah H. | Buy | 35 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
98.76 |
Last 83 transactions |
Buy: 1 749 377 489 | Sell: 16 641 486 |
Wolumen Korelacja
Skye Bioscience, Inc. Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Skye Bioscience, Inc. Korelacja - Waluta/Towar
Skye Bioscience, Inc. Finanse
Annual | 2022 |
Przychody: | $0 |
Zysk brutto: | $-114 998 (0.00 %) |
EPS: | $-9.82 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-114 998 (0.00 %) |
EPS: | $-9.82 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.0200 |
FY | 2020 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.0300 |
Financial Reports:
No articles found.
Skye Bioscience, Inc.
Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100, which is in Phase I trials for the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 that is in preclinical trials to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. was founded in 2012 and is headquartered in San Diego, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej